Investors should invest in CORT right now as the stock is doing extremely well in 2024 and its prospects look even brighter. As the U.S. stock market experiences a surge, led by a rally in the ...

Vandana Singh Corcept Moves 6.5% Higher: Will This Strength Last? Corcept Therapeutics (NASDAQ: CORT) shares soared 6.5% in the last trading session to close at $42.27. The move was backed by ...

Positive results from these trials could significantly boost CORT's revenue potential, especially in non-Cushing's applications like cancer and ALS. Corcept's academic alliances enhance its ...

Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big ...

NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on mid-month and end-of-month settlement dates. It is then ...